145 related articles for article (PubMed ID: 29582549)
1. Microglial immune response is impaired against the neurotropic fungus Lomentospora prolificans.
Pellon A; Ramirez-Garcia A; Guruceaga X; Zabala A; Buldain I; Antoran A; Anguita J; Rementeria A; Matute C; Hernando FL
Cell Microbiol; 2018 Aug; 20(8):e12847. PubMed ID: 29582549
[TBL] [Abstract][Full Text] [Related]
2. Insights into the interaction of Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporium minutisporum, and Lomentospora prolificans with lung epithelial cells.
de Mello TP; Aor AC; Branquinha MH; Dos Santos ALS
Braz J Microbiol; 2020 Jun; 51(2):427-436. PubMed ID: 31736016
[TBL] [Abstract][Full Text] [Related]
3. Peptidorhamnomannan from Lomentospora prolificans modulates the inflammatory response in macrophages infected with Candida albicans.
Xisto MIDDS; Santos SS; Rossato L; Yoshikawa FSY; Haido RMT; de Almeida SR; Barreto-Bergter E
BMC Microbiol; 2020 Aug; 20(1):245. PubMed ID: 32762645
[TBL] [Abstract][Full Text] [Related]
4. The Host Immune Response to
Buldain I; Martin-Souto L; Antoran A; Areitio M; Aparicio-Fernandez L; Rementeria A; Hernando FL; Ramirez-Garcia A
J Fungi (Basel); 2021 Jan; 7(2):. PubMed ID: 33499053
[TBL] [Abstract][Full Text] [Related]
5.
Furnica DT; Dittmer S; Scharmann U; Meis JF; Steinmann J; Rath PM; Kirchhoff L
Microbiol Spectr; 2023 Jun; 11(3):e0513022. PubMed ID: 37017567
[TBL] [Abstract][Full Text] [Related]
6. Peptidorhamnomannan negatively modulates the immune response in a scedosporiosis murine model.
Xisto MI; Liporagi-Lopes LC; Muñoz JE; Bittencourt VC; Santos GM; Dias LS; Figueiredo RT; Pinto MR; Taborda CP; Barreto-Bergter E
Med Mycol; 2016 Nov; 54(8):846-55. PubMed ID: 27343286
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope
Seidel D; Meißner A; Lackner M; Piepenbrock E; Salmanton-García J; Stecher M; Mellinghoff S; Hamprecht A; Durán Graeff L; Köhler P; Cheng MP; Denis J; Chedotal I; Chander J; Pakstis DL; Los-Arcos I; Slavin M; Montagna MT; Caggiano G; Mares M; Trauth J; Aurbach U; Vehreschild MJGT; Vehreschild JJ; Duarte RF; Herbrecht R; Wisplinghoff H; Cornely OA
Crit Rev Microbiol; 2019 Feb; 45(1):1-21. PubMed ID: 30628529
[TBL] [Abstract][Full Text] [Related]
8. An Alpha-Glucan from
Xisto MIDDS; Dias LDS; Bezerra FF; Bittencourt VCB; Rollin-Pinheiro R; Cartágenes-Pinto AC; Haido RMT; Mourão PAS; Barreto-Bergter E
J Fungi (Basel); 2023 Feb; 9(3):. PubMed ID: 36983458
[No Abstract] [Full Text] [Related]
9. Glucosylceramides From
Xisto MIDDS; Henao JEM; Dias LDS; Santos GMP; Calixto ROR; Bernardino MC; Taborda CP; Barreto-Bergter E
Front Microbiol; 2019; 10():554. PubMed ID: 30967849
[No Abstract] [Full Text] [Related]
10. Lomentospora prolificans fungemia in hematopoietic stem cell transplant patients: First report in South America and literature review.
Penteado FD; Litvinov N; Sztajnbok J; Thomaz DY; Dos Santos AM; Vasconcelos DM; Motta AL; Rossi F; Fernandes JF; Marques HHS; Benard G; de Almeida JN
Transpl Infect Dis; 2018 Aug; 20(4):e12908. PubMed ID: 29679424
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of auranofin and honokiol as antifungals against
Yaakoub H; Staerck C; Mina S; Godon C; Fleury M; Bouchara JP; Calenda A
Virulence; 2021 Dec; 12(1):1076-1090. PubMed ID: 33825667
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular responses of the pathogenic fungus Lomentospora prolificans to the antifungal drug voriconazole.
Pellon A; Ramirez-Garcia A; Buldain I; Antoran A; Rementeria A; Hernando FL
PLoS One; 2017; 12(3):e0174885. PubMed ID: 28362854
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against peptidorhamnomannans of Scedosporium apiospermum enhance the pathogenicity of the fungus.
Lopes LC; Rollin-Pinheiro R; Guimarães AJ; Bittencourt VC; Martinez LR; Koba W; Farias SE; Nosanchuk JD; Barreto-Bergter E
PLoS Negl Trop Dis; 2010 Oct; 4(10):e853. PubMed ID: 20976055
[TBL] [Abstract][Full Text] [Related]
14. Identifying the emerging human pathogen Scedosporium prolificans by using a species-specific monoclonal antibody that binds to the melanin biosynthetic enzyme tetrahydroxynaphthalene reductase.
Thornton CR; Ryder LS; Le Cocq K; Soanes DM
Environ Microbiol; 2015 Apr; 17(4):1023-38. PubMed ID: 24684242
[TBL] [Abstract][Full Text] [Related]
15. GROWTH-INHIBITORY EFFECTS OF FARNESOL AGAINST SCEDOSPORIUM BOYDII AND LOMENTOSPORA PROLIFICANS.
Pumeesat P; Wongsuk T; Muangkaew W; Luplertlop N
Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):170-8. PubMed ID: 29644833
[TBL] [Abstract][Full Text] [Related]
16. Dihydroorotate dehydrogenase inhibitor F901318 has potent in vitro activity against Scedosporium species and Lomentospora prolificans.
Wiederhold NP; Law D; Birch M
J Antimicrob Chemother; 2017 Jul; 72(7):1977-1980. PubMed ID: 28333310
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope
Jenks JD; Seidel D; Cornely OA; Chen S; van Hal S; Kauffman C; Miceli MH; Heinemann M; Christner M; Jover Sáenz A; Burchardt A; Kemmerling B; Herbrecht R; Steinmann J; Shoham S; Gräber S; Pagano L; Deeren D; Slavin MA; Hoenigl M
Mycoses; 2020 May; 63(5):437-442. PubMed ID: 32080902
[TBL] [Abstract][Full Text] [Related]
18. Cyclophilin and enolase are the most prevalent conidial antigens of Lomentospora prolificans recognized by healthy human salivary IgA and cross-react with Aspergillus fumigatus.
Buldain I; Ramirez-Garcia A; Pellon A; Antoran A; Sevilla MJ; Rementeria A; Hernando FL
Proteomics Clin Appl; 2016 Oct; 10(9-10):1058-1067. PubMed ID: 27485921
[TBL] [Abstract][Full Text] [Related]
19. Host immune response against Scedosporium species.
Roilides E; Simitsopoulou M; Katragkou A; Walsh TJ
Med Mycol; 2009 Jun; 47(4):433-40. PubMed ID: 19184770
[TBL] [Abstract][Full Text] [Related]
20. Study of Humoral Responses against
Buldain I; Pellon A; Zaldibar B; Antoran A; Martin-Souto L; Aparicio-Fernandez L; Areitio M; Mayayo E; Rementeria A; Hernando FL; Ramirez-Garcia A
Vaccines (Basel); 2019 Dec; 7(4):. PubMed ID: 31835471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
